Trial intelligence / Profile preview

PANFLU.1 in Infants 6-35 Months

NCT01047202Phase 4Completed

Sponsor
Sinovac Biotech Ltd.
Start
Dec 2009
Primary completion
Mar 2010
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of Panflu.1 in influenza A/H1N1 (H1N1), sponsored by Sinovac Biotech Ltd.. Started Dec 2009; status: completed.

02

Drugs

Panflu.1
03

Conditions

influenza A/H1N1 (H1N1)

Beyond the preview

Go deeper on NCT01047202.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01047202.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call